drugset / Trial / NCT05858814
RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT
NaSingle-groupOpen-labelPrevention
Summary
To evaluate the safety and tolerability of RC1012 injection infusion in AML Patients after Allo-HSCT
Timeline
- Start
- 2023-05-04
- Primary completion
- 2024-05-27
- Completion
- 2026-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RC1012 | Cell therapy | 1e+08 cells/kg | Other |
| Subject | RC1012 | Cell therapy | 1.5e+08 cells/kg | Other |